Nektar Therapeutics (NKTR) Assets (2010 - 2026)
Nektar Therapeutics (NKTR) posted quarterly Assets of $763.3 million for Q1 2026, up 197.87% year-over-year from $256.2 million in Q1 2025, and up 172.2% quarter-over-quarter from $280.4 million in Q4 2025.
Nektar Therapeutics (NKTR) Assets (2010 - 2026) Analysis & Trends
Nektar Therapeutics' Assets history runs 17 years deep, the most recent figure standing at $763.3 million for Q1 2026.
- In Q1 2026, Assets rose 197.87% year-over-year to $763.3 million; the TTM figure through Mar 2026 stood at $763.3 million (up 197.87% YoY), while the FY2025 annual figure was $280.4 million, down 7.72% from the prior year.
- Assets for Q1 2026 stood at $763.3 million, up from $280.4 million in the prior quarter.
- The five-year high for Assets was $1.0 billion in Q1 2022, with the low at $207.5 million in Q2 2025.
- The 5-year median for Assets is $398.0 million (2023), against an average of $496.1 million.
- The sharpest annual moves came in 2023 and 2026: Assets plunged 45.15% in 2023, then soared 197.87% in 2026.
- Nektar Therapeutics' Assets stood at $710.6 million in 2022, then sank by 43.99% to $398.0 million in 2023, then retreated by 23.66% to $303.8 million in 2024, then retreated by 7.72% to $280.4 million in 2025, then soared by 172.2% to $763.3 million in 2026.
- Business Quant data shows NKTR's Assets at $763.3 million in Q1 2026, $280.4 million in Q4 2025, and $301.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Nektar Therapeutics | 1.49 Bn | 919.46 Mn | 3.16 Mn | 763.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 763.27 Mn |
| Dec 31, 2025 | 280.41 Mn |
| Sep 30, 2025 | 301.35 Mn |
| Jun 30, 2025 | 207.53 Mn |
| Mar 31, 2025 | 256.24 Mn |
| Dec 31, 2024 | 303.85 Mn |
| Sep 30, 2024 | 307.97 Mn |
| Jun 30, 2024 | 343.33 Mn |
| Mar 31, 2024 | 396.01 Mn |
| Dec 31, 2023 | 398.03 Mn |
| Sep 30, 2023 | 442.24 Mn |
| Jun 30, 2023 | 494.28 Mn |
| Mar 31, 2023 | 561.74 Mn |
| Dec 31, 2022 | 710.60 Mn |
| Sep 30, 2022 | 781.01 Mn |
| Jun 30, 2022 | 861.99 Mn |
| Mar 31, 2022 | 1.02 Bn |
| Dec 31, 2021 | 1.12 Bn |
| Sep 30, 2021 | 1.28 Bn |
| Jun 30, 2021 | 1.37 Bn |